TOHO-Lipid Intervention trial using Pitavastatin (TOHO-LIP) in patients with high risk hypercholesterolemia - 96 weeks reports Chronic Kidney Disease sub-analysis
Author
K Shirai, M Takahashi, H Noike, T Shiba, H Hara, T Fujioka, G Yoshino, K Wagatsuma, A Namiki, J Yamazaki, Y Iwasaki, S Yamamura, K Sugi